IN2013MU03310A - - Google Patents
Info
- Publication number
- IN2013MU03310A IN2013MU03310A IN3310MU2013A IN2013MU03310A IN 2013MU03310 A IN2013MU03310 A IN 2013MU03310A IN 3310MU2013 A IN3310MU2013 A IN 3310MU2013A IN 2013MU03310 A IN2013MU03310 A IN 2013MU03310A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutically acceptable
- acceptable derivative
- sulbactam
- imipenem
- disclosed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/030,005 US20160310472A1 (en) | 2013-10-22 | 2014-10-21 | Pharmaceutical compositions comprising sulbactam and imipenem |
PCT/IB2014/065496 WO2015059629A1 (en) | 2013-10-22 | 2014-10-21 | Pharmaceutical compositions comprising sulbactam and imipenem |
EP14802501.8A EP3060212A1 (en) | 2013-10-22 | 2014-10-21 | Pharmaceutical compositions comprising sulbactam and imipenem |
IN3310MU2013 IN2013MU03310A (ru) | 2013-10-22 | 2014-10-21 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3310MU2013 IN2013MU03310A (ru) | 2013-10-22 | 2014-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU03310A true IN2013MU03310A (ru) | 2015-07-31 |
Family
ID=51947405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3310MU2013 IN2013MU03310A (ru) | 2013-10-22 | 2014-10-21 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20160310472A1 (ru) |
EP (1) | EP3060212A1 (ru) |
IN (1) | IN2013MU03310A (ru) |
WO (1) | WO2015059629A1 (ru) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129382B (zh) * | 2006-08-25 | 2013-12-25 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和缓冲组分的抗生素复方 |
FR2955028B1 (fr) * | 2010-01-13 | 2012-03-02 | Centre Nat Rech Scient | Traitement des infections par les chlamydiaceae par les beta-lactames |
CN102349896B (zh) * | 2011-07-22 | 2013-03-27 | 广州定慧医药科技有限公司 | 一种亚胺培南西司他丁舒巴坦的药物组合物 |
US9095594B2 (en) * | 2011-07-26 | 2015-08-04 | Wockhardt Ltd. | Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor |
-
2014
- 2014-10-21 WO PCT/IB2014/065496 patent/WO2015059629A1/en active Application Filing
- 2014-10-21 US US15/030,005 patent/US20160310472A1/en not_active Abandoned
- 2014-10-21 IN IN3310MU2013 patent/IN2013MU03310A/en unknown
- 2014-10-21 EP EP14802501.8A patent/EP3060212A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20160310472A1 (en) | 2016-10-27 |
WO2015059629A1 (en) | 2015-04-30 |
EP3060212A1 (en) | 2016-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020005181A (es) | Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam). | |
EP3082817A4 (en) | Compositions for drug administration | |
EP3129048A4 (en) | Antibodies, pharmaceutical compositions and uses thereof | |
IL243627A (en) | High-power pancreatic pharmaceuticals | |
TW201144301A (en) | Processes for preparing linezolid | |
IL284419A (en) | Pharmaceutical preparations of pancreatin with high potency | |
EP3731832A4 (en) | CANNABINOID DOSAGE FORM | |
MX2016008369A (es) | Composicion farmaceutica que incluye palonosetron. | |
EP3048103A4 (en) | Immune adjustment compound, use thereof and pharmaceutical composition comprising same | |
IL252897A0 (en) | Indanyl compounds, pharmaceutical preparations and their medical uses | |
MX2017001487A (es) | Sofosbuvir en forma cristalina y proceso para su preparacion. | |
GEP201706739B (en) | Compositions comprising vortioxetine and donepezil | |
HK1213800A1 (zh) | 類毒素、組合物及相關方法 | |
IN2013MU01985A (ru) | ||
MX363631B (es) | Composiciones y metodos para tratar infecciones bacterianas. | |
EP3190129A4 (en) | Centrally-acting peptide derivative, and pharmaceutical composition | |
IL238851A0 (en) | The history of pyrrolidine, pharmaceutical preparations and their uses | |
HK1213810A1 (zh) | 施用和相關的組合物、方法和系統 | |
PH12017502148A1 (en) | Pharmaceutical compositions and use thereof | |
PH12017500071A1 (en) | Therapeutic agent for keratoconjunctive disorder | |
IN2013MU03422A (ru) | ||
IN2013MU03370A (ru) | ||
MX2016005160A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
IN2013MU03310A (ru) | ||
GEP20196989B (en) | Pharmaceutical composition comprising bisoprolol and perindoril |